This announcement is a separate document:
江苏世纪同仁律师事务所关于江苏康缘药业股份有限公司2022年度限制性股票激励计划回购注销部分限制性股票实施情况的法律意见书
Legal Opinion of Jiangsu Century Tongren Law Firm on the implementation of the 2022 Restricted Stock Incentive Plan of Jiangsu Kangyuan Pharmaceutical Co., Ltd. to repurchase and cancel some restricted stocks
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated